Cargando…

Ovarian Hyperandrogenism and Response to Gonadotropin-releasing Hormone Analogues in Primary Severe Insulin Resistance

CONTEXT: Insulin resistance (IR) is associated with polycystic ovaries and hyperandrogenism, but underpinning mechanisms are poorly understood and therapeutic options are limited. OBJECTIVE: To characterize hyperandrogenemia and ovarian pathology in primary severe IR (SIR), using IR of defined molec...

Descripción completa

Detalles Bibliográficos
Autores principales:	Huang-Doran, Isabel, Kinzer, Alexandra B, Jimenez-Linan, Mercedes, Thackray, Kerrie, Harris, Julie, Adams, Claire L, de Kerdanet, Marc, Stears, Anna, O’Rahilly, Stephen, Savage, David B, Gorden, Phillip, Brown, Rebecca J, Semple, Robert K
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2021
Materias:	Clinical Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8277216/ https://www.ncbi.nlm.nih.gov/pubmed/33901270 http://dx.doi.org/10.1210/clinem/dgab275

Ejemplares similares

Gonadotropin-Releasing Hormone Analogue Stimulation Test Versus Venous Sampling in Postmenopausal Hyperandrogenism
por: Tng, Eng-Loon, et al.
Publicado: (2020)

The metabolic syndrome- associated small G protein ARL15 plays a role in adipocyte differentiation and adiponectin secretion
por: Rocha, Nuno, et al.
Publicado: (2017)

Roux-en-Y Gastric Bypass Surgery in the Management of Familial Partial Lipodystrophy Type 1
por: Melvin, Audrey, et al.
Publicado: (2017)

Mitochondrial Oxidative Phosphorylation Is Impaired in Patients with Congenital Lipodystrophy
por: Sleigh, Alison, et al.
Publicado: (2012)

Describing the natural history of clinical, biochemical and radiological outcomes of children with familial partial lipodystrophy type 2 (FPLD2) from the United Kingdom: A retrospective case series
por: Zhong, Zhu Xuan, et al.
Publicado: (2022)

Early preclinical work with gonadotropin-releasing hormone analogues
por: Gordon, Keith
Publicado: (2023)

SAT-291 Gonadotropin Releasing Hormone Agonist Therapy Improves Hyperandrogenism in an Adolescent with Type A Insulin Resistance Syndrome
por: Paprocki, Emily, et al.
Publicado: (2019)

Utilisation of gonadotrophin-releasing hormone (GnRH) analogue to differentiate ovarian from adrenal hyperandrogenism in postmenopausal women
por: Bahaeldein, E, et al.
Publicado: (2018)

Trajectories of Adolescents Treated with Gonadotropin-Releasing Hormone Analogues for Gender Dysphoria
por: Brik, Tessa, et al.
Publicado: (2020)

The Hormonal Control of Food Intake
por: Coll, Anthony P., et al.
Publicado: (2007)

A Case of Cyclic Vomiting Syndrome Responding to Gonadotropin-Releasing Hormone Analogue
por: Shin, Young Kook, et al.
Publicado: (2010)

Anaphylactic reaction to gonadotropin‐releasing hormone analogues: a pediatric case report
por: Ricci, Franco, et al.
Publicado: (2018)

The impact of hyperandrogenism on the outcomes of ovulation induction using gonadotropin and intrauterine insemination in women with polycystic ovary syndrome
por: Ho, Vu Ngoc Anh, et al.
Publicado: (2022)

GDF15: A Hormone Conveying Somatic Distress to the Brain
por: Lockhart, Samuel M, et al.
Publicado: (2020)

The Anticancer Activity Compared Between Triptorelin and a New Gonadotropin Releasing Hormone Analogue
por: Saleh-Abady, Mohammad Mirzaei, et al.
Publicado: (2009)

Clinical applications of gonadotropin-releasing hormone analogues: a broad impact on reproductive medicine
por: Saleh, Farrah L., et al.
Publicado: (2023)

Effects of Gonadotropin-Releasing Hormone (GnRH) and Its Analogues on the Physiological Behaviors and Hormone Content of Tetrahymena pyriformis
por: Lajkó, Eszter, et al.
Publicado: (2019)

Gonadotropin-releasing hormone analogue and recombinant human growth hormone treatment for idiopathic central precocious puberty in girls
por: Shi, Yuzhen, et al.
Publicado: (2022)

Association of Gonadotropin-Releasing Hormone Analogue Use With Subsequent Use of Gender-Affirming Hormones Among Transgender Adolescents
por: Nos, Andrea L., et al.
Publicado: (2022)

Postmenopausal Hyperandrogenism
por: Lal, Rayhan A, et al.
Publicado: (2018)

Body image and depression in girls with idiopathic precocious puberty treated with gonadotropin-releasing hormone analogue
por: Choi, Min-Seon, et al.
Publicado: (2016)

Gonadotropin-Releasing Hormone Analogue Treatment in Females with Moderately Early Puberty: No Effect on Final Height
por: Savaş-Erdeve, Şenay, et al.
Publicado: (2016)

Deficiency of Gpr1 improves steroid hormone abnormality in hyperandrogenized mice
por: Yang, Ya-Li, et al.
Publicado: (2018)

Hormone-induced sperm-release in the critically endangered Booroolong frog (Litoria booroolongensis): effects of gonadotropin-releasing hormone and human chorionic gonadotropin
por: Silla, Aimee J, et al.
Publicado: (2019)

Final height outcome of boys with idiopathic central precocious puberty treated with gonadotropin-releasing hormone analogue
por: Ma, Hua-mei, et al.
Publicado: (2013)

Effect of gonadotropin-releasing hormone analogue on final adult height among Jordanian children with precocious puberty
por: Swaiss, Hala H., et al.
Publicado: (2017)

Incidence of Idiopathic Intracranial Hypertension in Individuals With Gonadotropin-Releasing Hormone Analogue Treatment for Gender Dysphoria in Sweden
por: Karamanis, Georgios, et al.
Publicado: (2023)

SAT376 Luteinizing Hormone Secretion in Hyperandrogenic Girls Taking Spironolactone or Metformin
por: Burt Solorzano, Christine Michele, et al.
Publicado: (2023)

Aromatase inhibitors with or without gonadotropin-releasing hormone analogue in metastatic male breast cancer: a case series
por: Zagouri, F, et al.
Publicado: (2013)

Role of gonadotropin-releasing hormone analogues in metastatic male breast cancer: results from a pooled analysis
por: Di Lauro, Luigi, et al.
Publicado: (2015)

An evaluation of gonadotropin-releasing hormone analogue administered to gilts and sows on subsequent reproductive performance and piglet birth weight
por: Vangroenweghe, Frédéric, et al.
Publicado: (2016)

Anatomía de Gardner
por: O'Rahilly, Ronan
Publicado: (1989)

“Treasure Your Exceptions”—Studying Human Extreme Phenotypes to Illuminate Metabolic Health and Disease: The 2019 Banting Medal for Scientific Achievement Lecture
por: O’Rahilly, Stephen
Publicado: (2021)

Human Frame Shift Mutations Affecting the Carboxyl Terminus of Perilipin Increase Lipolysis by Failing to Sequester the Adipose Triglyceride Lipase (ATGL) Coactivator AB-hydrolase-containing 5 (ABHD5)
por: Gandotra, Sheetal, et al.
Publicado: (2011)

Effect of triiodothyronine on hyperandrogenism in women
por: Kazanavicius, Gintautas, et al.
Publicado: (2013)

Female hyperandrogenism and elite sport
por: Hirschberg, Angelica Lindén
Publicado: (2020)

Gonadotropin releasing hormone analogue (GnRHa) alters the expression and activation of Smad in human endometrial epithelial and stromal cells
por: Luo, Xiaoping, et al.
Publicado: (2003)

Efficacy and safety of a 4-year combination therapy of growth hormone and gonadotropin-releasing hormone analogue in pubertal girls with short predicted adult height
por: Dotremont, Hilde, et al.
Publicado: (2023)

Development of the gonadotropin‐releasing hormone system
por: Duittoz, Anne H., et al.
Publicado: (2022)

Dual trigger with gonadotropin-releasing hormone and human chorionic gonadotropin for poor responders
por: Eser, Ahmet, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_dgalg99vrvdokjfqq97ptctqr0